FP
Flagship Pioneering Portfolio holdings
AUM
$268M
This Quarter Return
-5.95%
1 Year Return
-54.4%
3 Year Return
-51.2%
5 Year Return
+66.7%
10 Year Return
–
AUM
$1.51B
AUM Growth
+$1.51B
(+190%)
Cap. Flow
+$919M
Cap. Flow
% of AUM
60.75%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
RUBY
Rubius Therapeutics, Inc
RUBY
|
$919M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RUBY
1
DELISTED
Rubius Therapeutics, Inc
RUBY
| $919M | 60.75% |
+38,296,526
| New | +$919M |
|
|
EVLO
2
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $222M | 14.68% |
18,233,403
| – | – |
|
3
Denali Therapeutics
DNLI
$2.23B
| $194M | 12.82% |
8,918,749
| – | – |
|
4
Seres Therapeutics
MCRB
$166M
| $96.3M | 6.36% |
12,682,876
| – | – |
|
5
Quanterix
QTRX
$211M
| $43.5M | 2.87% |
2,030,495
| – | – |
|
|
SYRS
6
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $38.2M | 2.52% |
3,204,437
| – | – |
|